35480-46-7 Usage
Classification
Nonsteroidal anti-inflammatory drug (NSAID)
Function
Reduces pain and inflammation in conditions such as arthritis by inhibiting the production of certain chemicals in the body that cause pain and inflammation
Additional Use
Treatment of acute myocardial infarction and transient ischemic attacks, as it can help prevent blood clots from forming and reduce the risk of further cardiovascular events
Administration
Orally in the form of tablets or capsules
Side Effects
May include gastrointestinal discomfort, bleeding, and allergic reactions
Importance
An effective and valuable medication for managing pain and inflammation associated with various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 35480-46-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,4,8 and 0 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 35480-46:
(7*3)+(6*5)+(5*4)+(4*8)+(3*0)+(2*4)+(1*6)=117
117 % 10 = 7
So 35480-46-7 is a valid CAS Registry Number.
35480-46-7Relevant articles and documents
Palladium-Catalyzed C-H Trifluoroethoxylation of N-Sulfonylbenzamides
Yang, Long,Li, Shangda,Cai, Lei,Ding, Yongzheng,Fu, Lei,Cai, Zhihua,Ji, Huafang,Li, Gang
supporting information, p. 2746 - 2749 (2017/05/24)
The trifluoroethyl aryl ethers are important motifs in drug molecules. However, a report devoted specifically to the study of transition-metal-catalyzed C-H trifluoroethoxylation has not been reported to date. A protocol of Pd(II)-catalyzed o-C-H trifluor
Novel process for the preparation of flecainide, its pharmaceutically acceptable salts and important intermediates thereof
-
Page/Page column 4, (2010/02/11)
Process for the preparation of Flecainide, its pharmaceutically acceptable salts and important intermediates thereof that involves the use of the 2-halobenzoic acid and its derivatives as a starting material. The use of this process also allows for the synthesis of a novel intermediate useful in the production of Flecainide. This new process is an inexpensive and efficient process for the manufacture of these compounds.
